Myriam Chalabi

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

The next 25 years of cancer research: emerging perspectives and priorities.

The next 25 years of cancer research: emerging perspectives and priorities.

Journal: Nature reviews. Cancer

Published: August 06, 2026

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Journal: Histopathology

Published: February 05, 2026

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 21, 2026

Early successes in colon immunotherapy.

Early successes in colon immunotherapy.

Journal: Nature medicine

Published: January 06, 2026

Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study.

Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study.

Journal: BMJ open

Published: December 17, 2025

Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial.

Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: December 16, 2025

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Journal: Cancer treatment reviews

Published: November 25, 2025

Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Journal: Nature

Published: January 23, 2025

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)

Published: December 09, 2024

Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.

Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.

Journal: The New England journal of medicine

Published: November 27, 2024

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

Journal: Nature cancer

Published: October 07, 2024

The emerging role of immunotherapy-based strategies in nonmetastatic colorectal cancer.

The emerging role of immunotherapy-based strategies in nonmetastatic colorectal cancer.

Journal: Clinical advances in hematology & oncology : H&O

Published: October 02, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026